A second shot of Johnson & Johnson’s COVID-19 vaccine reduced the risk of hospitalization from the omicron variant by 85 percent during a clinical trial.
Read the full post on Becker's Hospital Review - Healthcare News
J&J: 2 shots of vaccine lower risk of omicron hospitalization by 85%
